Abstract |
In rheumatoid arthritis (RA), a chronic inflammatory disease, loss of muscle mass is an important contributor to the loss of muscle strength in RA patients. Myostatin, a myokine involved in the process of muscle hypertrophy and myogenesis, enhances osteoclast differentiation and inflammation. Here, we investigated the mechanisms of myostatin in RA synovial inflammation. We found a positive correlation between myostatin and tumor necrosis factor-α (TNF-α), a well-known proinflammatory cytokine, in RA synovial tissue. Our in vitro results also showed that myostatin dose-dependently induced TNF-α expression through the phosphatidylinositol 3-kinase (PI3K)-Akt-AP-1 signaling pathway. Myostatin treatment of human MH7A cells stimulated AP-1-induced luciferase activity and activation of the c-Jun binding site on the TNF-α promoter. Our results indicated that myostatin increases TNF-α expression via the PI3K-Akt-AP-1 signaling pathway in human RA synovial fibroblasts. Myostatin appears to be a promising target in RA therapy.
|
Authors | Chen-Ming Su, Sung-Lin Hu, Yi Sun, Jin Zhao, Chengqian Dai, Lihong Wang, Guohong Xu, Chih-Hsin Tang |
Journal | Journal of cellular physiology
(J Cell Physiol)
Vol. 234
Issue 6
Pg. 9793-9801
(06 2019)
ISSN: 1097-4652 [Electronic] United States |
PMID | 30378113
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2018 Wiley Periodicals, Inc. |
Chemical References |
- Myostatin
- Transcription Factor AP-1
- Tumor Necrosis Factor-alpha
- Proto-Oncogene Proteins c-akt
|
Topics |
- Arthritis, Rheumatoid
(metabolism)
- Cell Line
- Fibroblasts
(metabolism)
- Gene Expression Regulation
(drug effects)
- Humans
- Myostatin
(pharmacology)
- Phosphatidylinositol 3-Kinases
(genetics, metabolism)
- Proto-Oncogene Proteins c-akt
(genetics, metabolism)
- Signal Transduction
- Synovial Membrane
(drug effects, metabolism)
- Transcription Factor AP-1
(genetics, metabolism)
- Tumor Necrosis Factor-alpha
(genetics, metabolism)
|